NCT06119256 2026-04-02
Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT
Chinese PLA General Hospital
Phase 1 Recruiting
Clinical Trials
27 trialsNCT06908096 2026-03-30
Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT07478952 2026-03-24
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age
ModernaTX, Inc.
Phase 1 Recruiting
NCT06256484 2026-03-11
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Atara Biotherapeutics
Phase 1 Terminated
NCT05389423 2026-02-19
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT04664179 2025-12-12
CILESTE
Baylor College of Medicine
Phase 1 Recruiting
NCT06789159 2025-10-20
A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
Thomas Jefferson University
Phase 1 Recruiting
NCT05831111 2025-09-30
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
ModernaTX, Inc.
Phase 1 Active not recruiting
NCT04013802 2025-08-08
TETRAVI
Baylor College of Medicine
Phase 1 Recruiting
NCT06926894 2025-07-31
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Columbia University
Phase 1 Recruiting
NCT04645147 2025-07-17
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection
National Institutes of Health Clinical Center (CC)
Phase 1 Active not recruiting
NCT01494103 2025-07-11
DOTTI
Baylor College of Medicine
Phase 1 Active not recruiting
NCT06429800 2025-04-24
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus
Atara Biotherapeutics
Phase 1 Withdrawn
NCT05183490 2024-12-30
R-MVST Cells for Treatment of Viral Infections
Columbia University
Phase 1 Recruiting
NCT06135922 2023-11-18
Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
Chinese PLA General Hospital
Phase 1 Recruiting
NCT01535885 2021-10-25
ACE
Medical College of Wisconsin
Phase 1 Completed
NCT00058591 2020-01-18
SCAEBV
Baylor College of Medicine
Phase 1 Completed
NCT00058604 2020-01-18
EUCLID
Baylor College of Medicine
Phase 1 Completed
NCT01800071 2018-07-17
A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
Cancer Research UK
Phase 1 Completed
NCT02761291 2016-05-16
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Chang Gung Memorial Hospital
Phase 1 Unknown
NCT00706316 2015-07-10
NPC-CTL
University Health Network, Toronto
Phase 1 Completed
NCT00058812 2015-01-29
ETNA
Baylor College of Medicine
Phase 1 Completed
NCT01070797 2014-09-04
VIRAGE
Baylor College of Medicine
Phase 1 Completed
NCT00078546 2012-07-30
CLANC
Baylor College of Medicine
Phase 1 Completed
NCT00779337 2012-05-22
EPL
Queensland Institute of Medical Research
Phase 1 Completed
NCT01147991 2012-02-28
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer
Cancer Research UK
Phase 1 Completed
NCT01256853 2011-12-22
Modified Vaccinia Ankara (MVA) Vaccine Study
Chinese University of Hong Kong
Phase 1 Completed